GE Healthcare and Leading Korean Hospital Aim to Accelerate AI Ecosystem Using GE’s New Edison Digital Health Platform

Seoul National University Bundang Hospital to leverage GE Healthcare’s artificial intelligence (AI) capabilities to take the lead in using medical AI in their hospital system. The two collaborators intend to support and accelerate Korean start-ups to test and develop clinical applications on Edison Digital Health Platform Seoul, South Korea – March 31, 2022 — GE... Read more

Antiviral Actions of Polyphosphates against SARS-CoV-2 Variants Visualized with Super-resolution Microscopy

The global spread of COVID-19 with its relatively high mortality rate presents a current challenge to medical researchers to develop therapeutic strategies. Long-chain, inorganic polyphosphates are chains of inorganic phosphate units. These are found in many cells in our blood and are cytoprotective with antiviral activities, including against HIV-1 infection. We spoke with Dr. Massimo... Read more

Driving New Discoveries With Lattice Light Sheet Microscopy in an Advanced Core Imaging Facility

The Centre for Dynamic Imaging (CDI) at the Walter and Eliza Hall Institute of Medical Research (WEHI) in Parkville, Victoria (Australia) is both a core facility and a research lab for advanced microscopy helping scientists use advanced imaging technology and powerful computational resources to generate detailed and real-time views of biological systems. These new insights... Read more

Microscopy as a Hobby

While many microscopists work in research, clinical or educational settings, there is also a small group who spend their spare time enjoying microscopy as a hobby. Quite a few submissions for our ZEISS Microscopy Image Contest 2021 came from hobby microscopists. Enjoy their beautiful images and thoughts on microscopy as a hobby: Michael Witzke, Germany... Read more

WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19

WHO’s prequalification adds to several mechanisms already in place to improve access to Actemra/RoActemra for people with COVID-19 in low- and middle-income countries Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra, as recommended in global treatment guidelines Twelfth Roche medicine or test to be... Read more